Subject: Pam Weintraub argues with the FDA and CDC officer Alan
Barbour?
Date: Mar 12, 2009 11:04 AM
"***In contrast, when the flagella-less microorganisms of the present
invention are used for immunization, one can simply assay an
individual exhibiting symptoms characteristic of a selected borrelial
pathogenesis, such as Lyme disease, for antibodies to the flagellar-
antigen. In such individuals, the absence of such antibodies will
usually weigh against a diagnosis of Borreliosis, and their presence
will be suggestive of a vaccine failure.***"
http://www.actionlyme.org/index.htm
I understand Pam Weintraub refutes the FDA and their Bioanalytics
Division Rules on the Validation of an Analytical Method.
I hope she has the sense to take her arguments up with the FDA and
stops attacking Lyme victims for repeating what those rules are, and
also demonstrating what Yale claims to have developed as a validated
method for detecting Lyme Borreliosis- a method that is SPECIFIC for
Lyme Borrelia and detects 17/18 cases:
▲Here is the original 1991 Fikrig/Flavell report that goes with the
USPTO.gov # 5,618,533 patent:
http://iai.asm.org/cgi/reprint/59/10/3531?view=long&pmid=1894359
Look at the graphic on page 3533.
▲Yale's Fikrig and Flavell are clearly selecting out a section of
flagellar DNA that does not cross react with antibodies against
flagella from other organisms, which means it is a SPECIFIC test for
Borrelia burgdorferi flagellin antibodies, which almost all Lyme
victims have.
Why wasn't this test used to assess the outcome of Yale's other,
later, patent, the LYMErix vaccine?
Even CDC "officer" Alan Barbour in US patent 5,436,000 proposed such a
concept when he patented the flagellar-less spirochete:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5,436,000.PN.&OS=PN/5,436,000&RS=PN/5,436,000
"***In contrast, when the flagella-less microorganisms of the present
invention are used for immunization, one can simply assay an
individual exhibiting symptoms characteristic of a selected borrelial
pathogenesis, such as Lyme disease, ***for antibodies to the flagellar-
antigen.*** In such individuals, the absence of such antibodies will
usually weigh against a diagnosis of Borreliosis, and their presence
will be suggestive of a vaccine failure.***"
===============
I hope Pam can settle this with the FDA
because if the FDA or Yale is not doing
this science right, I am sure they would
like to hear about it from Ms. Weintraub.
It make no sense for Weintraub to attack
*us* - other Lyme victims - if she has an
issue with the FDA's Bioanalytics Division
or Alan Barbour of the CDC's proposal to
vaccinate with a flagella-less borrelia
and then test for vaccine failure with
a scientifically validated - SPECIFIC TO
BURGDORFERI - method of detecting Borrelial
flagellar antibodies.
As you can see, I did not imaginate these
statements, claims or experiments.
Kathleen M. Dickson
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci
Just for the record-----the FDA- CDC and dept of Hlth and Human svces
are all as crooked as ben Ladin's walking stick.....